Roll on genetics of PARK and Parkinsonism in the developing world

Kalaria, Raj N.; Akinyemi, Rufus

doi:10.1136/jnnp.2008.162834

Cited by 1 publication

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Highly powered, large sample, multicenter collaborative projects of uniform methodologies are needed to unravel the novel genetic, epigenetic and gene–environment interactions that influence the phenomics, natural history and outcome of PD in Africans [48]. …”

Section: Perspectives On What Is Knownmentioning

confidence: 99%

Neurogenomics in Africa: Perspectives, progress, possibilities and priorities

Akinyemi

Owolabi

Oyeniyi

et al. 2016

Journal of the Neurological Sciences

View full text Add to dashboard Cite

The understanding of the genetic basis of neurological disorders has grown rapidly in the last two decades. Despite the genomic heterogeneity within African populations, large-scale candidate gene or linkage and exome studies are lacking. However, current knowledge on neurogenetics in African populations is limited and geographically very uneven. Isolated reports indicate the existence of autosomal dominant or recessive conditions incorporating cerebrovascular, movement, neuromuscular, seizure and motor neuron disorders in Africans. In addition, few African families with neurodegenerative disorders associated with dementia have been characterized in North, West and South Africa. The current insurgency in genomic research triggered by among others the Human Health and Heredity (H3) Africa Initiative indicates that there are unique opportunities to advance our knowledge and understanding of the influence of genomic variation on the pattern, presentations and prognosis of neurological disorders in Africa. These have enormous potential to unmask novel genes and molecular pathways germane to the neurobiology of brain disorders. It would facilitate the development of novel diagnostics, preventative and targeted treatments in the new paradigm of precision medicine. Nevertheless, it is crucial to strike a balance between effective traditional public health strategies and personalized genome based care. The translational barriers can be overcome through robust stakeholder engagement and sustainable multilevel, multigenerational and multidisciplinary capacity building and infrastructural development for genomic medicine in Africa.

show abstract

Section: Perspectives On What Is Knownmentioning

confidence: 99%